Diseases [C] » Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] » Genetic Diseases, Inborn » Primary Immunodeficiency Diseases
Diseases [C] » Immune System Diseases [C20] » Immunologic Deficiency Syndromes » Primary Immunodeficiency Diseases
Description
Genetic immunologic deficiency diseases and syndromes due to mutations in genes involved in IMMUNITY generally characterized by an increased susceptibility to infectious diseases. They are often associated with AUTOIMMUNE DISEASE manifestations. MeSH
Hierarchy View
Subtype Terms (9)
Ataxia Telangiectasia
29 drugs (27 approved, 2 experimental)
Chediak-Higashi Syndrome
20 drugs (19 approved, 1 experimental)
Hereditary Complement Deficiency Diseases
1 experimental drug
Hyper-IgM Immunodeficiency Syndrome
8 drugs (7 approved, 1 experimental)
Job Syndrome
5 drugs (3 approved, 2 experimental)
Leukocyte-Adhesion Deficiency Syndrome
10 approved drugs
Severe Combined Immunodeficiency
39 drugs (25 approved, 14 experimental)
Wiskott-Aldrich Syndrome
34 drugs (25 approved, 9 experimental)
Phase 3 Indicated Drugs (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
